Comparison of venous thromboembolism incidence in newly diagnosed multiple myeloma patients receiving bortezomib, lenalidomide, dexamethasone (RVD) or carfilzomib, lenalidomide, dexamethasone (KRD) with aspirin or rivaroxaban thromboprophylaxis

Primary prevention of venous thromboembolism with apixaban for multiple myeloma patients receiving immunomodulatory agents

(2020) Robert F. Cornell et al.   BRITISH JOURNAL OF HAEMATOLOGY

Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer

(2020) Giancarlo Agnelli et al.   NEW ENGLAND JOURNAL OF MEDICINE

Carfilzomib or bortezomib in combination with lenalidomide and dexamethasone for patients with newly diagnosed multiple myeloma without intention for immediate autologous stem-cell transplantation (ENDURANCE): a multicentre, open-label, phase 3, randomised, controlled trial

(2020) Shaji K Kumar et al.   LANCET ONCOLOGY

Derivation and Validation of a Risk Assessment Model for Immunomodulatory Drug–Associated Thrombosis Among Patients With Multiple Myeloma

(2019) Ang Li et al.   Journal of the National Comprehensive Cancer Network

Carfilzomib with immunomodulatory drugs for the treatment of newly diagnosed multiple myeloma

(2019) Ola Landgren et al.   LEUKEMIA

Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)

(2018) Annie M. Young et al.   JOURNAL OF CLINICAL ONCOLOGY

Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism

(2018) Gary E. Raskob et al.   NEW ENGLAND JOURNAL OF MEDICINE

Carfilzomib and the cardiorenal system in myeloma: an endothelial effect?

(2016) A Rosenthal et al.   Blood Cancer Journal

Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH

(2015) S. Kaatz et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Treatment With Carfilzomib-Lenalidomide-Dexamethasone With Lenalidomide Extension in Patients With Smoldering or Newly Diagnosed Multiple Myeloma

(2015) Neha Korde et al.   JAMA Oncology

Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based study

(2010) S. Y. Kristinsson et al.   BLOOD

Deep vein thrombosis after monoclonal gammopathy of undetermined significance and multiple myeloma

(2008) S. Y. Kristinsson et al.   BLOOD